Kenneth K. Tanabe - Concepedia

Author

Kenneth K. Tanabe

Also Known As

Aapro, Matti S, Daniel S. Tan, K K Tanabe, K Tanabe, K. K. Tanabe, K. Tanabe, K.K. Tanabe, Katsuhiro Ichimaru, Kenneth K Tanabe, Kenneth K. Tanabe

529

Publications

19.8K

Citations

H-Index

136

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Athinoula A. Martinos Center for Biomedical Imaging The University of Texas MD Anderson Cancer Center Harvard University Press

About

Kenneth K. Tanabe is an author at Massachusetts General Hospital specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	88	7.4K
2	Health Sciences	23	27	2.4K
3	Engineering	5	5	273
4	Public Health	3	3	77
5	Natural Sciences	1	1	93

Kenneth K. Tanabe

193

Publications

17.8K

Citations

H-Index

Page 1

	Year	Citations
Frequent Mutation of Isocitrate Dehydrogenase<i>(IDH)1</i>and<i>IDH2</i>in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping Darrell R. Borger, Kenneth K. Tanabe, Kenneth C. Fan, The Oncologist	2011	702
Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. S. Nahum Goldberg, G. Scott Gazelle, Carolyn C. Compton, PubMed	2000	586
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma Robert J. Soiffer, Thomas J. Lynch, Martin Mihm, Proceedings of the National Academy of Sciences	1998	578
Percutaneous Radiofrequency Tissue Ablation: Does Perfusion-mediated Tissue Cooling Limit Coagulation Necrosis? S. Nahum Goldberg, Peter F. Hahn, Kenneth K. Tanabe, Journal of Vascular and Interventional Radiology HyperthermiaRadiofrequency HeatingVascular SurgeryThermal TherapyInterventional Radiology	1998	544
Treatment of intrahepatic malignancy with radiofrequency ablation S. Nahum Goldberg, G. Scott Gazelle, Carolyn C. Compton, Cancer Surgical OncologyMultimodalityInterventional RadiologySurgeryMagnetic Resonance Imaging	2000	513
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Theodore S. Hong, Jennifer Y. Wo, Beow Y. Yeap, Journal of Clinical Oncology	2015	461
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology Daniel G. Coit, John A. Thompson, Mark R. Albertini, Journal of the National Comprehensive Cancer Network Tumor BiologySurgical OncologyBraf-targeted TherapyMedicineMelanoma	2019	432
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma James Lally, Sarani Ghoshal, Danielle K. DePeralta, Cell Metabolism OxysterolBiochemistryMedicineLiver PhysiologyAcetyl-coa Carboxylase	2018	395
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma Lipika Goyal, Lei Shi, Leah Y. Liu, Cancer Discovery	2019	363
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma Bryan C. Fuchs, Yujin Hoshida, Tsutomu Fujii, Hepatology	2013	357

Page 1